PCN105 COST SAVINGS ASSOCIATED WITH BEVACIZUMAB-BASED THERAPY IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72000-9
https://www.valueinhealthjournal.com/article/S1098-3015(11)72000-9/fulltext
Title :
PCN105 COST SAVINGS ASSOCIATED WITH BEVACIZUMAB-BASED THERAPY IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72000-9&doi=10.1016/S1098-3015(11)72000-9
First page :
A271
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
159